VTE prophylaxis (hospitalized medical patients)

vte-prophylaxis-medical · society: ASH

← back to Hematology & Oncology

Summary

ASH 2018 evidence-based guidelines on VTE prevention in hospitalized and nonhospitalized medical patients, including acutely ill inpatients, critically ill inpatients, chronically ill/long-term care residents, outpatients with minor provoking factors, and long-distance travelers. Nineteen GRADE-based recommendations address pharmacologic vs mechanical prophylaxis, agent selection (UFH, LMWH, fondaparinux, DOACs, aspirin), duration, and post-discharge extension. Strong recommendations include pharmacologic prophylaxis for acutely/critically ill inpatients at acceptable bleeding risk, LMWH over DOACs in hospital, and against extended outpatient prophylaxis after discharge.

Current guideline: ASH 2018 VTE Prophylaxis Guideline · download Anki sub-deck

Versions

• 2018 · ASH — ASH 2018 VTE Prophylaxis Guideline
  • Read the guideline: html · pmc · Anki deck

---

Table of contents

• 2018 · ASH